Logo image of SNEX

STONEX GROUP INC (SNEX) Stock Fundamental Analysis

NASDAQ:SNEX - US8618961085 - Common Stock

98.84 USD
+2.88 (+3%)
Last: 8/22/2025, 8:00:02 PM
98.84 USD
0 (0%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

4

SNEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. SNEX has a bad profitability rating. Also its financial health evaluation is rather negative. SNEX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SNEX was profitable.
SNEX had a positive operating cash flow in the past year.
In the past 5 years SNEX has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: SNEX reported negative operating cash flow in multiple years.
SNEX Yearly Net Income VS EBIT VS OCF VS FCFSNEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

SNEX has a worse Return On Assets (0.84%) than 65.97% of its industry peers.
SNEX has a Return On Equity of 14.51%. This is in the better half of the industry: SNEX outperforms 79.41% of its industry peers.
SNEX's Return On Invested Capital of 1.33% is on the low side compared to the rest of the industry. SNEX is outperformed by 67.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNEX is significantly below the industry average of 7.58%.
Industry RankSector Rank
ROA 0.84%
ROE 14.51%
ROIC 1.33%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
SNEX Yearly ROA, ROE, ROICSNEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of SNEX (0.22%) is worse than 72.69% of its industry peers.
In the last couple of years the Profit Margin of SNEX has remained more or less at the same level.
Looking at the Operating Margin, with a value of 0.30%, SNEX is doing worse than 72.69% of the companies in the same industry.
SNEX's Operating Margin has been stable in the last couple of years.
The Gross Margin of SNEX (1.89%) is worse than 71.43% of its industry peers.
SNEX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.3%
PM (TTM) 0.22%
GM 1.89%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
SNEX Yearly Profit, Operating, Gross MarginsSNEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

2

2. Health

2.1 Basic Checks

The number of shares outstanding for SNEX has been increased compared to 1 year ago.
SNEX has more shares outstanding than it did 5 years ago.
SNEX has a worse debt/assets ratio than last year.
SNEX Yearly Shares OutstandingSNEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNEX Yearly Total Debt VS Total AssetsSNEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

SNEX has an Altman-Z score of 3.51. This indicates that SNEX is financially healthy and has little risk of bankruptcy at the moment.
SNEX's Altman-Z score of 3.51 is fine compared to the rest of the industry. SNEX outperforms 78.99% of its industry peers.
SNEX has a debt to FCF ratio of 16.47. This is a negative value and a sign of low solvency as SNEX would need 16.47 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.47, SNEX is in line with its industry, outperforming 50.42% of the companies in the same industry.
SNEX has a Debt/Equity ratio of 8.24. This is a high value indicating a heavy dependency on external financing.
SNEX has a worse Debt to Equity ratio (8.24) than 87.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.24
Debt/FCF 16.47
Altman-Z 3.51
ROIC/WACCN/A
WACCN/A
SNEX Yearly LT Debt VS Equity VS FCFSNEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SNEX has a Current Ratio of 0.47. This is a bad value and indicates that SNEX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNEX has a worse Current ratio (0.47) than 76.05% of its industry peers.
A Quick Ratio of 0.47 indicates that SNEX may have some problems paying its short term obligations.
SNEX has a worse Quick ratio (0.47) than 75.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
SNEX Yearly Current Assets VS Current LiabilitesSNEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

8

3. Growth

3.1 Past

SNEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.07%, which is quite impressive.
SNEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.13% yearly.
The Revenue has grown by 53.18% in the past year. This is a very strong growth!
Measured over the past years, SNEX shows a very strong growth in Revenue. The Revenue has been growing by 24.87% on average per year.
EPS 1Y (TTM)22.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%-2.66%
Revenue 1Y (TTM)53.18%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%4.23%

3.2 Future

The Earnings Per Share is expected to grow by 10.55% on average over the next years. This is quite good.
SNEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.92% yearly.
EPS Next Y13.85%
EPS Next 2Y18.53%
EPS Next 3Y10.55%
EPS Next 5YN/A
Revenue Next Year15.24%
Revenue Next 2Y18.89%
Revenue Next 3Y9.92%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNEX Yearly Revenue VS EstimatesSNEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
SNEX Yearly EPS VS EstimatesSNEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

SNEX is valuated correctly with a Price/Earnings ratio of 16.84.
The rest of the industry has a similar Price/Earnings ratio as SNEX.
Compared to an average S&P500 Price/Earnings ratio of 27.24, SNEX is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.26, SNEX is valued correctly.
SNEX's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, SNEX is valued a bit cheaper.
Industry RankSector Rank
PE 16.84
Fwd PE 13.26
SNEX Price Earnings VS Forward Price EarningsSNEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNEX is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SNEX is valued cheaper than 82.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.21
EV/EBITDA 9.78
SNEX Per share dataSNEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.22
PEG (5Y)0.76
EPS Next 2Y18.53%
EPS Next 3Y10.55%

0

5. Dividend

5.1 Amount

No dividends for SNEX!.
Industry RankSector Rank
Dividend Yield N/A

STONEX GROUP INC

NASDAQ:SNEX (8/22/2025, 8:00:02 PM)

After market: 98.84 0 (0%)

98.84

+2.88 (+3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-17 2025-11-17/amc
Inst Owners82.46%
Inst Owner Change0.15%
Ins Owners10.12%
Ins Owner Change11.89%
Market Cap5.16B
Analysts87.5
Price Target117.3 (18.68%)
Short Float %3%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.55%
Min EPS beat(2)-13.86%
Max EPS beat(2)4.76%
EPS beat(4)3
Avg EPS beat(4)4.17%
Min EPS beat(4)-13.86%
Max EPS beat(4)14.81%
EPS beat(8)7
Avg EPS beat(8)6.01%
EPS beat(12)10
Avg EPS beat(12)9.26%
EPS beat(16)13
Avg EPS beat(16)14.58%
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)0.48%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)1.92%
Revenue beat(8)4
Avg Revenue beat(8)-2.65%
Revenue beat(12)8
Avg Revenue beat(12)651.41%
Revenue beat(16)12
Avg Revenue beat(16)1673.36%
PT rev (1m)3.6%
PT rev (3m)38.55%
EPS NQ rev (1m)7.39%
EPS NQ rev (3m)13.74%
EPS NY rev (1m)1.65%
EPS NY rev (3m)1.65%
Revenue NQ rev (1m)7.24%
Revenue NQ rev (3m)20.87%
Revenue NY rev (1m)5.19%
Revenue NY rev (3m)5.03%
Valuation
Industry RankSector Rank
PE 16.84
Fwd PE 13.26
P/S 0.04
P/FCF 5.21
P/OCF 4.9
P/B 2.61
P/tB 2.73
EV/EBITDA 9.78
EPS(TTM)5.87
EY5.94%
EPS(NY)7.46
Fwd EY7.54%
FCF(TTM)18.98
FCFY19.2%
OCF(TTM)20.16
OCFY20.4%
SpS2507.55
BVpS37.94
TBVpS36.23
PEG (NY)1.22
PEG (5Y)0.76
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 14.51%
ROCE 6.02%
ROIC 1.33%
ROICexc 1.41%
ROICexgc 1.5%
OM 0.3%
PM (TTM) 0.22%
GM 1.89%
FCFM 0.76%
ROA(3y)0.99%
ROA(5y)0.96%
ROE(3y)16.74%
ROE(5y)16.85%
ROIC(3y)2.05%
ROIC(5y)1.73%
ROICexc(3y)2.29%
ROICexc(5y)1.95%
ROICexgc(3y)2.5%
ROICexgc(5y)2.13%
ROCE(3y)6.36%
ROCE(5y)5.86%
ROICexcg growth 3Y11.83%
ROICexcg growth 5Y4.45%
ROICexc growth 3Y11.82%
ROICexc growth 5Y4.25%
OM growth 3Y-1.36%
OM growth 5Y1.16%
PM growth 3Y-1.69%
PM growth 5Y-0.17%
GM growth 3Y-15.32%
GM growth 5Y-4.82%
F-Score5
Asset Turnover3.82
Health
Industry RankSector Rank
Debt/Equity 8.24
Debt/FCF 16.47
Debt/EBITDA 33.64
Cap/Depr 70.24%
Cap/Sales 0.05%
Interest Coverage 0.28
Cash Conversion 216.98%
Profit Quality 344.79%
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 3.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)80.55%
Cap/Depr(5y)85.05%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.07%
EPS 3Y26.7%
EPS 5Y22.13%
EPS Q2Q%-2.66%
EPS Next Y13.85%
EPS Next 2Y18.53%
EPS Next 3Y10.55%
EPS Next 5YN/A
Revenue 1Y (TTM)53.18%
Revenue growth 3Y32.92%
Revenue growth 5Y24.87%
Sales Q2Q%4.23%
Revenue Next Year15.24%
Revenue Next 2Y18.89%
Revenue Next 3Y9.92%
Revenue Next 5YN/A
EBIT growth 1Y23.72%
EBIT growth 3Y31.11%
EBIT growth 5Y26.32%
EBIT Next Year63.14%
EBIT Next 3Y-15.66%
EBIT Next 5YN/A
FCF growth 1Y672.2%
FCF growth 3Y-40.15%
FCF growth 5Y19.18%
OCF growth 1Y919.56%
OCF growth 3Y-37.96%
OCF growth 5Y20.98%